• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工神经网络的肝癌差异表达序列标签的生物信息学解构。

Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network.

机构信息

Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China.

Department of Gastroenterology, Jiujiang First People's Hospital, Jiujiang 332000, Jiangxi, China.

出版信息

Contrast Media Mol Imaging. 2022 Oct 10;2022:6716324. doi: 10.1155/2022/6716324. eCollection 2022.

DOI:10.1155/2022/6716324
PMID:36299828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9576451/
Abstract

Traditional medical imaging methods for diagnosing hepatocellular carcinoma can only provide information for differential diagnosis in terms of morphology and blood supply of the lesion, and the determination of the nature of the lesion still relies on tissue biopsy. Although ultrasound or CT-guided biopsy has become an effective method for the diagnosis of liver cancer in recent years, the puncture has the possibility of tumor irritation, liver tumor rupture, or needle tract metastasis. In this paper, the use of bioinformatics method is to gradually screen potentially high-risk genes associated with HCC recurrence on a genome-wide scale would help to discover the key target molecules. The ANN method was used to establish a gene prediction model that can predict the recurrence and survival of HCC, so as to construct a tool to identify patients at risk of HCC recurrence. It provided a certain therapeutic basis for future clinical work, thereby improving the prognosis of patients with HCC. Using the "survfit" function of the "survival" package in the R language, the log-rank test (the log-rank test was a common method for comparing two survival curves) was performed on all genes with posthoc recurrence of hepatocellular carcinoma as the outcome event. Then, the BLAST tool (Basic Local Alignment Search Tool) was used to search the similarity of each hepatocellular carcinoma database to find out the genes with similar sequences to each hepatocellular carcinoma, so as to determine the function of each differentially expressed sequence tag. This paper found that the AUC of the ANN model was greater than that of the discriminant analysis model ( < 0.05). This paper promoted the development of new therapeutic measures for hepatocellular carcinoma and provided important theoretical guidance for human beings to fight cancer.

摘要

传统的医学影像学方法只能提供病变形态和血供方面的鉴别诊断信息,病变性质的确定仍依赖于组织活检。尽管近年来超声或 CT 引导下的活检已成为诊断肝癌的有效方法,但穿刺仍有肿瘤刺激、肝癌破裂或针道转移的可能。本文运用生物信息学方法,逐步筛选出全基因组范围内与 HCC 复发相关的潜在高危基因,有助于发现关键的靶分子。ANN 方法用于建立基因预测模型,可以预测 HCC 的复发和生存,从而构建一种识别 HCC 复发风险患者的工具。为未来的临床工作提供了一定的治疗基础,从而改善 HCC 患者的预后。使用 R 语言“survival”包中的“survfit”函数,以肝癌的术后复发作为结局事件,对所有肝癌复发的基因进行对数秩检验(对数秩检验是比较两条生存曲线的常用方法)。然后,使用 BLAST 工具(Basic Local Alignment Search Tool)搜索每个肝癌数据库之间的相似性,找出与每个肝癌具有相似序列的基因,从而确定每个差异表达序列标签的功能。本文发现 ANN 模型的 AUC 大于判别分析模型(<0.05)。本文推动了肝癌新治疗措施的发展,为人类抗癌提供了重要的理论指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/4ac3de473e27/CMMI2022-6716324.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/9fe83a6eb8e7/CMMI2022-6716324.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/efb142bdcd52/CMMI2022-6716324.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/7bbc68e23aa4/CMMI2022-6716324.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/a51a16a0131f/CMMI2022-6716324.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/c778e567528b/CMMI2022-6716324.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/d2271c46e0ff/CMMI2022-6716324.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/9ba790fba8da/CMMI2022-6716324.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/924cd4723fb2/CMMI2022-6716324.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/d682b18e03f7/CMMI2022-6716324.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/4ac3de473e27/CMMI2022-6716324.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/9fe83a6eb8e7/CMMI2022-6716324.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/efb142bdcd52/CMMI2022-6716324.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/7bbc68e23aa4/CMMI2022-6716324.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/a51a16a0131f/CMMI2022-6716324.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/c778e567528b/CMMI2022-6716324.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/d2271c46e0ff/CMMI2022-6716324.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/9ba790fba8da/CMMI2022-6716324.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/924cd4723fb2/CMMI2022-6716324.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/d682b18e03f7/CMMI2022-6716324.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f9/9576451/4ac3de473e27/CMMI2022-6716324.010.jpg

相似文献

1
Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network.基于人工神经网络的肝癌差异表达序列标签的生物信息学解构。
Contrast Media Mol Imaging. 2022 Oct 10;2022:6716324. doi: 10.1155/2022/6716324. eCollection 2022.
2
Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.综合分析竞争内源性 RNA 网络揭示了预测肝细胞癌复发的潜在生物标志物。
BMC Cancer. 2021 Apr 20;21(1):436. doi: 10.1186/s12885-021-08173-0.
3
Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.生物信息学分析鉴定用于预测肝细胞癌转移的多信使 RNA 标志物。
DNA Cell Biol. 2020 Nov;39(11):2028-2039. doi: 10.1089/dna.2020.5513. Epub 2020 Sep 10.
4
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
5
Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.基于生物信息学的肝细胞癌关键基因及药物筛选的综合分析
Curr Pharm Biotechnol. 2023;24(8):1035-1058. doi: 10.2174/1389201023666220628113452.
6
Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.基于统计与生物信息学综合分析方法构建并验证用于预测肝细胞癌患者总生存期的预后基因模型
Int J Mol Sci. 2021 Feb 5;22(4):1632. doi: 10.3390/ijms22041632.
7
Analysis of potential key genes in very early hepatocellular carcinoma.分析极早期肝细胞癌中的潜在关键基因。
World J Surg Oncol. 2019 May 1;17(1):77. doi: 10.1186/s12957-019-1616-6.
8
Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma.免疫系统相关基因促进肝癌恶性进展,并可用于预测肝癌患者的临床结局。
Int J Oncol. 2020 May;56(5):1199-1211. doi: 10.3892/ijo.2020.4998. Epub 2020 Feb 24.
9
[Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].基于生物信息学分析筛选核心基因及细胞周期蛋白B2作为肝细胞癌潜在的诊断、治疗及预后生物标志物
Zhonghua Gan Zang Bing Za Zhi. 2020 Sep 20;28(9):773-783. doi: 10.3760/cma.j.cn501113-20200818-00461.
10
[Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].[甲胎蛋白高低水平的肝细胞癌患者基因表达谱的差异分析]
Zhonghua Zhong Liu Za Zhi. 2020 May 23;42(5):396-402. doi: 10.3760/cma.j.cn112152-112152-20191115-00740.

引用本文的文献

1
Retracted: Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network.撤回:基于人工神经网络的肝细胞癌差异表达序列标签的生物信息解构
Contrast Media Mol Imaging. 2023 Nov 29;2023:9797605. doi: 10.1155/2023/9797605. eCollection 2023.

本文引用的文献

1
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives.肝细胞癌的化疗:当前证据与未来展望
J Clin Transl Hepatol. 2017 Sep 28;5(3):235-248. doi: 10.14218/JCTH.2017.00002. Epub 2017 Jun 8.
2
MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1.微小RNA-490-5p通过直接调控ROBO1抑制肝癌细胞的增殖、迁移和侵袭。
Pathol Oncol Res. 2019 Jan;25(1):1-9. doi: 10.1007/s12253-017-0305-4. Epub 2017 Sep 19.
3
Deciphering the protein-protein interaction network regulating hepatocellular carcinoma metastasis.
解析调控肝细胞癌转移的蛋白质-蛋白质相互作用网络。
Biochim Biophys Acta Proteins Proteom. 2017 Sep;1865(9):1114-1122. doi: 10.1016/j.bbapap.2017.06.005. Epub 2017 Jun 14.
4
Viral hepatitis and hepatocellular carcinoma: etiology and management.病毒性肝炎与肝细胞癌:病因与管理
J Gastrointest Oncol. 2017 Apr;8(2):229-242. doi: 10.21037/jgo.2017.03.14.
5
Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.长链非编码RNA UCA1通过miR-203调控Snail2的表达以促进肝细胞癌进展。
J Cancer Res Clin Oncol. 2017 Jun;143(6):981-990. doi: 10.1007/s00432-017-2370-1. Epub 2017 Mar 8.
6
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study.索拉非尼的靶向毒性可预测肝细胞癌患者生存率的提高:一项多中心前瞻性研究。
Aliment Pharmacol Ther. 2017 Apr;45(8):1146-1155. doi: 10.1111/apt.13977. Epub 2017 Mar 2.
7
Transarterial embolization for hepatocellular carcinoma: reasoning on mechanisms of action, tips and tricks of the procedure.经动脉栓塞治疗肝细胞癌:作用机制探讨、操作技巧与窍门
Eur J Gastroenterol Hepatol. 2017 Apr;29(4):488-489. doi: 10.1097/MEG.0000000000000804.
8
MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1.微小RNA-98-5p通过靶向IGF2BP1抑制肝癌细胞增殖并诱导细胞凋亡。
Oncol Res. 2017 Aug 7;25(7):1117-1127. doi: 10.3727/096504016X14821952695683. Epub 2016 Dec 21.
9
Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3.可溶性B7-H3对肝硬化患者肝细胞癌的早期检测
J Gastrointest Surg. 2017 May;21(5):807-812. doi: 10.1007/s11605-017-3386-1. Epub 2017 Feb 27.
10
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.微小RNA-155-5p通过PI3K/Akt信号通路抑制PTEN从而促进肝细胞癌进展。
Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19.